The ongoing conflict in Iran and the resulting disruption of traffic through the Strait of Hormuz are creating significant operational hurdles for medical manufacturers. Gentell, a Pennsylvania-based company specializing in medical dressings, is among the businesses grappling with a sharp increase in raw material costs. Because the firm relies heavily on oil and gas derivatives to produce its goods, it has seen some material expenses climb by as much as 30%.

Beyond the cost of raw materials, the logistics of maintaining a global supply chain have become increasingly expensive. Shipping costs have more than doubled in some instances, with the price of transporting a container from New Zealand to California rising from approximately $2,000 to $4,500. These logistical challenges are compounded by the fact that petrochemicals are essential components in thousands of everyday consumer products, ranging from pharmaceuticals to electronics.

For Gentell, the situation presents a difficult dilemma regarding pricing strategies. Because a significant portion of their business involves supplying nursing homes through U.S. government Medicare contracts, they are limited in their ability to immediately pass these rising costs on to the consumer. Company leadership has noted that while they are currently absorbing some of the margin crunch, a prolonged conflict will inevitably lead to price adjustments.

While the company has previously navigated supply chain disruptions during the pandemic, the current oil price shock remains a major concern. Executives are monitoring the situation closely, noting that even if the waterway were to reopen immediately, it would likely take months for global shipping traffic to stabilize. Should the conflict persist, the company has indicated that raising prices will become an unavoidable necessity to maintain operations.